Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 12
2004 6
2005 5
2006 7
2007 7
2008 2
2009 4
2010 4
2011 5
2012 7
2013 5
2014 3
2015 10
2016 1
2017 5
2018 7
2019 12
2020 16
2021 6
2022 11
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Anti-parkinsonian drugs today.
Nagai M. Nagai M. Nihon Rinsho. 2017 Jan;75(1):136-140. Nihon Rinsho. 2017. PMID: 30566307 English, Japanese.
[Preface].
Kawahata I, Nagai M. Kawahata I, et al. Among authors: nagai m. Nihon Yakurigaku Zasshi. 2024;159(1):1. doi: 10.1254/fpj.23099. Nihon Yakurigaku Zasshi. 2024. PMID: 38171829 Japanese. No abstract available.
Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy.
Yamanishi Y, Choudhury ME, Yoshida A, Hosokawa Y, Miyaue N, Tada S, Ando R, Murakami S, Miyamoto H, Nagai M. Yamanishi Y, et al. Among authors: nagai m. Mov Disord Clin Pract. 2022 Feb 20;9(3):362-368. doi: 10.1002/mdc3.13417. eCollection 2022 Apr. Mov Disord Clin Pract. 2022. PMID: 35402640 Free PMC article.
138 results